Literature DB >> 9575004

Compliance with medication regimens for mental and physical disorders.

J A Cramer1, R Rosenheck.   

Abstract

OBJECTIVE: The authors reviewed research on medication compliance in psychiatric treatment and compared compliance rates with compliance rates in treatment of physical disorders.
METHODS: MEDLINE was used to locate reports in the literature on medication compliance in psychiatric treatment for the years 1975 through 1996. These reports and studies cited in the reports were reviewed to determine the methods used to assess compliance and the compliance rates reported. Ten reports describing assessment methods and including medication compliance rates for antidepressant medication and 24 reports for antipsychotic medication were selected. They were compared with 12 reports that used microelectronic monitoring to assess medication compliance of patients with a range of nonpsychiatric disorders.
RESULTS: Studies of psychiatric patients used various methods of estimating medication compliance, including interviews with patients, clinicians' judgment, and pill counts, but overall showed low rates of compliance. Patients receiving antipsychotics took an average of 58 percent of the recommended amount of the medications, with a range from 24 to 90 percent. Patients receiving antidepressants took 65 percent of the recommended amount, with a range from 40 to 90 percent. The mean compliance rate for patients with physical disorders was 76 percent, with a range from 60 to 92 percent, although the microelectronic monitoring showed frequent omission of doses and discontinuation of medication.
CONCLUSIONS: Compliance with medication regimens among patients with psychiatric disorders may be lower than among patients with physical disorders. However, the difference may be largely attributable to the methods used for estimating compliance. The findings suggest the need for new and improved methods for monitoring compliance and increasing patients' compliance with pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575004     DOI: 10.1176/ps.49.2.196

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  128 in total

Review 1.  Therapeutic drug monitoring of psychotropic medications.

Authors:  P B Mitchell
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

2.  Adequacy of treatment for serious mental illness in the United States.

Authors:  Philip S Wang; Olga Demler; Ronald C Kessler
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308

3.  A study of treatment outcomes from atypical antipsychotic medications in the Virginia public system of community care.

Authors:  David M Ziegler; Thomas J Peachey
Journal:  Community Ment Health J       Date:  2003-04

4.  Effects of ethnicity on psychotropic medications adherence.

Authors:  Esperanza Diaz; Scott W Woods; Robert A Rosenheck
Journal:  Community Ment Health J       Date:  2005-10

5.  The future of pharmacotherapy for schizophrenia.

Authors:  John M Kane; Anil Malhotra
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

6.  A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine.

Authors:  Paul A Nakonezny; Carroll W Hughes; Taryn L Mayes; Kathryn H Sternweis-Yang; Betsy D Kennard; Matthew J Byerly; Graham J Emslie
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-10       Impact factor: 2.576

Review 7.  Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review.

Authors:  Nicole M Lanouette; David P Folsom; Andres Sciolla; Dilip V Jeste
Journal:  Psychiatr Serv       Date:  2009-02       Impact factor: 3.084

8.  Access and rational use of psychotropic medications in low- and middle-income countries.

Authors:  P Padmanathan; D Rai
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-21       Impact factor: 6.892

9.  Suicide Methods and Specific Types of Accidental Death and Fatal Poisoning Among Discharged Psychiatric Patients: A National Cohort Study.

Authors:  Florian Walter; Matthew J Carr; Pearl L H Mok; Sussie Antonsen; Carsten B Pedersen; Jenny Shaw; Roger T Webb
Journal:  J Clin Psychiatry       Date:  2018-10-02       Impact factor: 4.384

10.  Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatment.

Authors:  Celine M Laffont; Roberto Gomeni; Bo Zheng; Christian Heidbreder; Paul J Fudala; Azmi F Nasser
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.